Home
Vineti

Vineti Market Share Analysis for May 2026

learn more about vineti’s ptm® platform, the essential enterprise software solution for personalized therapies including cell and gene therapies and cancer vaccines.

Computers Electronics and Technology > Computers Electronics and Technology - Other

Domainvineti.com

Year Founded2016

Employees51 - 200

Annual Revenue$25M - $50M

Vineti

Vineti (including company regionals)

vineti.com

See more website traffic and engagement information

Vineti Revenue up to May 2026 is 25M - 50M

revenue generated by Vineti top domains

Vineti top domains revenue over 3 years

Revenue for Vineti top domains

vineti.com25M - 50M

See more with Sales Intelligence

Total visits to Vineti's top domains

Understand Vineti market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Vineti's top domains

Analyze Vineti engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Vineti's top domains

See how Vineti keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Vineti top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Vineti

These are the website technologies, by industry, used by Vineti top domains

Advertising (4)

DoubleClick

Audio Video Media (4)

Vimeo

Conversion & Analytics (4)

Google Analytics

Marketing (3)

Google Marketing Platform

More Technologies

11

See all

News & Signals from Vineti

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsKorber Group partnered with Vineti on Oct 1st '21.In Oct 2021, Korber announced cooperation with Vineti to connect their market-leading Personalized Therapy Management (PTM) technology with its Werum, PAS-X MES software.

NewsAutolomous LTD partnered with Vineti on Oct 1st '22.In October, Autolomous formed a strategic partnership with Vineti to deliver end-to-end supply chain management solutions for the CGT sector.

NewsVineti is developing end-to-end solution for cell and gene therapy supply chains.“Vineti is very excited to work with sedApta to develop a new end-to-end solution for cell and gene therapy supply chains and manufacturing,” said Vineti CEO Ann Klein.